Authors:
Allan, L
Hays, H
Jensen, NH
de Waroux, BL
Bolt, M
Donald, R
Kalso, E
Citation: L. Allan et al., Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain, BR MED J, 322(7295), 2001, pp. 1154-1158
Authors:
Montonen, M
Kalso, E
Pylkkaren, L
Lindstrorm, BM
Lingqvist, C
Citation: M. Montonen et al., Disodium clodronate in the treatment of diffuse sclerosing osteomyelitis (DSO) of the mandible, INT J OR M, 30(4), 2001, pp. 313-317
Authors:
Hanks, GW
de Conno, F
Cherny, N
Hanna, M
Kalso, E
McQuay, HJ
Mercadante, S
Meynadier, J
Poulain, P
Ripamonti, C
Radbruch, L
Casas, JRI
Sawe, J
Twycross, RG
Ventafridda, V
Citation: Gw. Hanks et al., Morphine and alternative opioids in cancer pain: the EAPC recommendations, BR J CANC, 84(5), 2001, pp. 587-593
Citation: M. Xu et al., Effects of radolmidine, a novel alpha(2-)adrenergic agonist compared with dexmedetomidine in different pain models in the rat, ANESTHESIOL, 93(2), 2000, pp. 473-481
Citation: E. Kalso, Peripheral opioids: a systematic review of intra-articular morphine, EVIDENCE BASED RESOURCE IN ANAESTHESIA AND ANALGESIA, 2000, pp. 137-155
Authors:
Xu, M
Wei, H
Kontinen, VK
Kalso, E
Pertovaara, A
Citation: M. Xu et al., The dissociation of sedative from spinal antinociceptive effects followingadministration of a novel alpha-2-adrenoceptor agonist, MPV-2426, in the locus coeruleus in the rat, ACT ANAE SC, 44(6), 2000, pp. 648-655
Citation: T. Tasmuth et al., Chronic post-treatment symptoms in patients with breast cancer operated indifferent surgical units, EUR J SUR O, 25(1), 1999, pp. 38-43
Authors:
Forssell, H
Kalso, E
Koskela, P
Vehmanen, R
Puukka, P
Alanen, P
Citation: H. Forssell et al., Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials, PAIN, 83(3), 1999, pp. 549-560
Authors:
Kontinen, VK
Kauppila, T
Paananen, S
Pertovaara, A
Kalso, E
Citation: Vk. Kontinen et al., Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy, PAIN, 80(1-2), 1999, pp. 341-346
Authors:
Vilim, FS
Aarnisalo, AA
Nieminen, ML
Lintunen, M
Karlstedt, K
Kontinen, VK
Kalso, E
States, B
Panula, P
Ziff, E
Citation: Fs. Vilim et al., Gene for pain modulatory neuropeptide NPFF: Induction in spinal cord by noxious stimuli, MOLEC PHARM, 55(5), 1999, pp. 804-811
Citation: M. Xu et al., Endogenous noradrenergic tone controls symptoms of allodynia in the spinalnerve ligation model of neuropathic pain, EUR J PHARM, 366(1), 1999, pp. 41-45
Citation: T. Heiskanen et al., Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics ofoxycodone, CLIN PHARM, 64(6), 1998, pp. 603-611